Device
N-butyl-2-cyanoacrylate
N-butyl-2-cyanoacrylate is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
60%
Ph phase_3
2
40%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Other(3)
Detailed Status
unknown3
Completed2
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 32 (40.0%)
N/A3 (60.0%)
Trials by Status
unknown360%
completed240%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
Comparing Tissue Adhesives in Port Site Closure
NCT05492721
unknownnot_applicable
Primary Prophylaxis of Gastric Variceal Bleed
NCT02468180
completednot_applicable
Secondary Prophylaxis of Gastric Variceal Bleed
NCT02468206
unknownnot_applicable
Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO
NCT02468167
unknownphase_3
Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection
NCT03388125
Clinical Trials (5)
Showing 5 of 5 trials
NCT05492721Phase 3
Comparing Tissue Adhesives in Port Site Closure
NCT02468180Not Applicable
Primary Prophylaxis of Gastric Variceal Bleed
NCT02468206Not Applicable
Secondary Prophylaxis of Gastric Variceal Bleed
NCT02468167Not Applicable
Acute Gastric Variceal Bleeding: Endoscopic Treatment Versus BRTO
NCT03388125Phase 3
Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5